Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Consideration ....
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital and Institute has informed the stock exchanges that its Board of Directors will meet on Wednesday, February 11, 2026. The main item on the agenda is the consideration and approval of the unaudited standalone financial results for the quarter and year ended December 31, 2025 (Q3 FY26 and 9M FY26). The company also confirmed that the trading window, which was closed for insiders ahead of the results, will reopen from February 13, 2026. The intimation has been filed under Regulation 29 of the SEBI LODR Regulations, 2015.
This is a routine pre-results announcement. Investors should watch for the Q3 FY26 standalone earnings release on or shortly after February 11, 2026, as it could influence short-term stock movement. No major corporate action (dividend, fundraising, or restructuring) is hinted at in this filing.